Annual SG&A
$0.00$8.45B-100.00%
Summary
- Current Value
- As of today, TMO annual SG&A is $0.00, down -100.00% on
- Historical Performance
- TMO annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- TMO annual SG&A is currently -100.00% below its historical high of $8.99B set on
- 3-Year Low Comparison
- TMO annual SG&A vs 3-year low value is unknown
- Sector Comparison
- TMO annual SG&A is higher than 39.58% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $2.16B | +3.0% | -2.1% | +35.8% | +210.3% | |
| TTM SG&A | $220.80B | +2638.1% | +2452.1% | +3543.0% | +7704.5% | |
| Price | $583.59 | +2.7% | +1.7% | +14.5% | +923.7% | |
| Annual Operating Expenses | $10.07B | +3.3% | +8.1% | +42.1% | +240.9% | |
| Annual Operating Profit | $7.66B | +2.9% | -25.7% | +79.9% | +585.4% | |
| Annual D&A | $3.11B | -8.8% | +19.9% | +36.5% | +294.8% | |
| Annual Revenue | $42.88B | +0.1% | +9.3% | +67.9% | +324.1% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.99B | N/A | -100.0% |
| 5Y | $8.99B | -100.0% | |
| All | $8.99B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of TMO?
As of today, TMO annual SG&A is $0.00
What is 1-year change in TMO annual SG&A?
TMO annual SG&A is down -100.00% year-over-year
What is 3-year change in TMO annual SG&A?
TMO annual SG&A is down -100.00% over the past 3 years
How far is TMO annual SG&A from its all-time high?
TMO annual SG&A is currently -100.00% below its historical high of $8.99B set on December 31, 2022
How does TMO annual SG&A rank versus sector peers?
TMO annual SG&A is higher than 39.58% of companies in Healthcare sector
When is TMO next annual earnings release?
The next annual earnings release for TMO is on
Quarterly SG&A
$2.16B$22.00M+1.03%
Summary
- Current Value
- As of today, TMO quarterly SG&A is $2.16B, up +1.03% on
- Historical Performance
- TMO quarterly SG&A is up +3.05% year-over-year, and down -2.08% over the past 3 years
- All-Time High Comparison
- TMO quarterly SG&A is currently -5.05% below its historical high of $2.28B set on
- 3-Year Low Comparison
- TMO quarterly SG&A is +29.31% above its 3-year low of $1.67B reached on
- Sector Comparison
- TMO quarterly SG&A is higher than 99.11% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $2.16B | +1.0% | +3.0% | -2.1% | +35.8% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $220.80B | +2605.3% | +2638.1% | +2452.1% | +3543.0% | |
| Price | $583.59 | +4.5% | +2.7% | +1.7% | +14.5% | |
| Quarterly Operating Expenses | $2.44B | -1.5% | +0.5% | -4.9% | +25.5% | |
| Quarterly Operating Profit | $2.15B | +10.6% | +13.1% | +22.6% | -9.9% | |
| Quarterly D&A | $661.00M | -3.6% | -10.6% | -21.1% | +15.0% | |
| Quarterly Revenue | $11.12B | +2.5% | +4.9% | +4.2% | +30.5% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.16B | at high | |
| 3Y | $2.18B | -1.0% | |
| 5Y | $2.28B | -5.0% | |
| All | $2.28B | -5.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.85B | N/A | +17.1% |
| 3Y | $1.67B | +29.3% | |
| 5Y | $1.67B | +29.3% | |
| All | -$92.40M | +2439.8% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of TMO?
As of today, TMO quarterly SG&A is $2.16B
What is TMO quarterly SG&A most recent change?
TMO quarterly SG&A was up +1.03% on September 27, 2025
What is 1-year change in TMO quarterly SG&A?
TMO quarterly SG&A is up +3.05% year-over-year
How far is TMO quarterly SG&A from its all-time high?
TMO quarterly SG&A is currently -5.05% below its historical high of $2.28B set on March 1, 2022
How does TMO quarterly SG&A rank versus sector peers?
TMO quarterly SG&A is higher than 99.11% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
TTM SG&A
$220.80B$5.93B+2.76%
Summary
- Current Value
- As of today, TMO TTM SG&A is $220.80B, up +2.76% on
- Historical Performance
- TMO TTM SG&A is up +2638.14% year-over-year, and up +2452.06% over the past 3 years
- All-Time High Comparison
- TMO TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- TMO TTM SG&A is +38.90% above its 3-year low of $158.96B reached on an earlier date
- Sector Comparison
- TMO TTM SG&A is higher than 99.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $220.80B | +2605.3% | +2638.1% | +2452.1% | +3543.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $2.16B | +1.0% | +3.0% | -2.1% | +35.8% | |
| Price | $583.59 | +4.5% | +2.7% | +1.7% | +14.5% | |
| TTM Operating Profit | $8.21B | +3.1% | +11.3% | -10.9% | +35.6% | |
| TTM D&A | $2.79B | -2.7% | -12.8% | -13.1% | +21.5% | |
| TTM Revenue | $43.74B | +1.2% | +3.2% | -1.0% | +53.5% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $220.80B | N/A | at high |
| 3Y | $220.80B | N/A | at high |
| 5Y | $220.80B | N/A | at high |
| All | $220.80B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $203.01B | N/A | +8.8% |
| 3Y | $158.96B | N/A | +38.9% |
| 5Y | $100.47B | N/A | +119.8% |
| All | $45.80M | N/A | >+9999.0% |
TTM SG&A History
FAQ
What is the current TTM SG&A of TMO?
As of today, TMO TTM SG&A is $220.80B
What is TMO TTM SG&A most recent change?
TMO TTM SG&A was up +2.76% on September 27, 2025
What is 1-year change in TMO TTM SG&A?
TMO TTM SG&A is up +2638.14% year-over-year
How far is TMO TTM SG&A from its all-time high?
TMO TTM SG&A is currently at its all-time high
How does TMO TTM SG&A rank versus sector peers?
TMO TTM SG&A is higher than 99.74% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- TMO Official Website www.thermofisher.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/97745/000009774525000159/0000097745-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774525000010/0000097745-25-000010-index.htm
- TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
- TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo